Cargando…

Predicting outcomes in rheumatoid arthritis related interstitial lung disease

The aim of this study was to compare radiology-based prediction models in rheumatoid arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis phenotype. RAILD patients had computed tomography (CT) scans scored visually and using CALIPER and forced vital ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Joseph, Hirani, Nikhil, van Moorsel, Coline H.M., Rajagopalan, Srinivasan, Murchison, John T., van Es, Hendrik W., Bartholmai, Brian J., van Beek, Frouke T., Struik, Marjolijn H.L., Stewart, Gareth A., Kokosi, Maria, Egashira, Ryoko, Brun, Anne Laure, Cross, Gary, Barnett, Joseph, Devaraj, Anand, Margaritopoulos, George, Karwoski, Ronald, Renzoni, Elisabetta, Maher, Toby M., Wells, Athol U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319797/
https://www.ncbi.nlm.nih.gov/pubmed/30487199
http://dx.doi.org/10.1183/13993003.00869-2018
_version_ 1783385127996358656
author Jacob, Joseph
Hirani, Nikhil
van Moorsel, Coline H.M.
Rajagopalan, Srinivasan
Murchison, John T.
van Es, Hendrik W.
Bartholmai, Brian J.
van Beek, Frouke T.
Struik, Marjolijn H.L.
Stewart, Gareth A.
Kokosi, Maria
Egashira, Ryoko
Brun, Anne Laure
Cross, Gary
Barnett, Joseph
Devaraj, Anand
Margaritopoulos, George
Karwoski, Ronald
Renzoni, Elisabetta
Maher, Toby M.
Wells, Athol U.
author_facet Jacob, Joseph
Hirani, Nikhil
van Moorsel, Coline H.M.
Rajagopalan, Srinivasan
Murchison, John T.
van Es, Hendrik W.
Bartholmai, Brian J.
van Beek, Frouke T.
Struik, Marjolijn H.L.
Stewart, Gareth A.
Kokosi, Maria
Egashira, Ryoko
Brun, Anne Laure
Cross, Gary
Barnett, Joseph
Devaraj, Anand
Margaritopoulos, George
Karwoski, Ronald
Renzoni, Elisabetta
Maher, Toby M.
Wells, Athol U.
author_sort Jacob, Joseph
collection PubMed
description The aim of this study was to compare radiology-based prediction models in rheumatoid arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis phenotype. RAILD patients had computed tomography (CT) scans scored visually and using CALIPER and forced vital capacity (FVC) measurements. Outcomes were evaluated using three techniques, as follows. 1) Scleroderma system evaluating visual interstitial lung disease extent and FVC values; 2) Fleischner Society idiopathic pulmonary fibrosis (IPF) diagnostic guidelines applied to RAILD; and 3) CALIPER scores of vessel-related structures (VRS). Outcomes were compared to IPF patients. On univariable Cox analysis, all three staging systems strongly predicted outcome (scleroderma system hazard ratio (HR) 3.78, p=9×10(−5); Fleischner system HR 1.98, p=2×10(−3); and 4.4% VRS threshold HR 3.10, p=4×10(−4)). When the scleroderma and Fleischner systems were combined, termed the progressive fibrotic system (C-statistic 0.71), they identified a patient subset (n=36) with a progressive fibrotic phenotype and similar 4-year survival to IPF. On multivariable analysis, with adjustment for patient age, sex and smoking status, when analysed alongside the progressive fibrotic system, the VRS threshold of 4.4% independently predicted outcome (model C-statistic 0.77). The combination of two visual CT-based staging systems identified 23% of an RAILD cohort with an IPF-like progressive fibrotic phenotype. The addition of a computer-derived VRS threshold further improved outcome prediction and model fit, beyond that encompassed by RAILD measures of disease severity and extent.
format Online
Article
Text
id pubmed-6319797
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-63197972019-01-07 Predicting outcomes in rheumatoid arthritis related interstitial lung disease Jacob, Joseph Hirani, Nikhil van Moorsel, Coline H.M. Rajagopalan, Srinivasan Murchison, John T. van Es, Hendrik W. Bartholmai, Brian J. van Beek, Frouke T. Struik, Marjolijn H.L. Stewart, Gareth A. Kokosi, Maria Egashira, Ryoko Brun, Anne Laure Cross, Gary Barnett, Joseph Devaraj, Anand Margaritopoulos, George Karwoski, Ronald Renzoni, Elisabetta Maher, Toby M. Wells, Athol U. Eur Respir J Original Articles The aim of this study was to compare radiology-based prediction models in rheumatoid arthritis-related interstitial lung disease (RAILD) to identify patients with a progressive fibrosis phenotype. RAILD patients had computed tomography (CT) scans scored visually and using CALIPER and forced vital capacity (FVC) measurements. Outcomes were evaluated using three techniques, as follows. 1) Scleroderma system evaluating visual interstitial lung disease extent and FVC values; 2) Fleischner Society idiopathic pulmonary fibrosis (IPF) diagnostic guidelines applied to RAILD; and 3) CALIPER scores of vessel-related structures (VRS). Outcomes were compared to IPF patients. On univariable Cox analysis, all three staging systems strongly predicted outcome (scleroderma system hazard ratio (HR) 3.78, p=9×10(−5); Fleischner system HR 1.98, p=2×10(−3); and 4.4% VRS threshold HR 3.10, p=4×10(−4)). When the scleroderma and Fleischner systems were combined, termed the progressive fibrotic system (C-statistic 0.71), they identified a patient subset (n=36) with a progressive fibrotic phenotype and similar 4-year survival to IPF. On multivariable analysis, with adjustment for patient age, sex and smoking status, when analysed alongside the progressive fibrotic system, the VRS threshold of 4.4% independently predicted outcome (model C-statistic 0.77). The combination of two visual CT-based staging systems identified 23% of an RAILD cohort with an IPF-like progressive fibrotic phenotype. The addition of a computer-derived VRS threshold further improved outcome prediction and model fit, beyond that encompassed by RAILD measures of disease severity and extent. European Respiratory Society 2019-01-03 /pmc/articles/PMC6319797/ /pubmed/30487199 http://dx.doi.org/10.1183/13993003.00869-2018 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Licence 4.0.
spellingShingle Original Articles
Jacob, Joseph
Hirani, Nikhil
van Moorsel, Coline H.M.
Rajagopalan, Srinivasan
Murchison, John T.
van Es, Hendrik W.
Bartholmai, Brian J.
van Beek, Frouke T.
Struik, Marjolijn H.L.
Stewart, Gareth A.
Kokosi, Maria
Egashira, Ryoko
Brun, Anne Laure
Cross, Gary
Barnett, Joseph
Devaraj, Anand
Margaritopoulos, George
Karwoski, Ronald
Renzoni, Elisabetta
Maher, Toby M.
Wells, Athol U.
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title_full Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title_fullStr Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title_full_unstemmed Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title_short Predicting outcomes in rheumatoid arthritis related interstitial lung disease
title_sort predicting outcomes in rheumatoid arthritis related interstitial lung disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319797/
https://www.ncbi.nlm.nih.gov/pubmed/30487199
http://dx.doi.org/10.1183/13993003.00869-2018
work_keys_str_mv AT jacobjoseph predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT hiraninikhil predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT vanmoorselcolinehm predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT rajagopalansrinivasan predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT murchisonjohnt predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT vaneshendrikw predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT bartholmaibrianj predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT vanbeekfrouket predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT struikmarjolijnhl predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT stewartgaretha predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT kokosimaria predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT egashiraryoko predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT brunannelaure predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT crossgary predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT barnettjoseph predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT devarajanand predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT margaritopoulosgeorge predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT karwoskironald predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT renzonielisabetta predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT mahertobym predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease
AT wellsatholu predictingoutcomesinrheumatoidarthritisrelatedinterstitiallungdisease